Human recombinant soluble ACE2 in severe COVID-19

Affiliations

• ¹ Department of Medicine 4, Kaiser Franz Josef Hospital-Clinic Favoriten, Vienna, Austria. Electronic address: alexander.zoufaly@gesundheitsverbund.at.
• ² Attoquant Diagnostics GmbH, Vienna, Austria.
• ³ Center of Virology, Medical University Vienna, Vienna, Austria.
• ⁴ Department of Medicine 4, Kaiser Franz Josef Hospital-Clinic Favoriten, Vienna, Austria.
• ⁵ Department of Pharmacy, Kaiser Franz Josef Hospital-Clinic Favoriten, Vienna, Austria.
• ⁶ CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
• ⁷ Department of Laboratory Medicine, Karolinska institute, Stockholm, Sweden.
• ⁸ Catalan Institution for Research and Advanced Studies (ICREA), Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Technology (BIST) Barcelona, Spain.
• ⁹ Keenan Research Center, Li Ka Shing Knowledge Institute, St Michael's Hospital, Unity Health Toronto, University of Toronto, Toronto, ON Canada.
• ¹⁰ Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.